MATRADE Enhances Export Opportunities for Malaysian Healthcare Sector at SEACare 2024
THURSDAY, 29 FEBRUARY 2024, KUALA LUMPUR: The Malaysia External Trade Development Corporation (MATRADE) is steadfast in its efforts to capitalise on current market trends which aim to elevate export prospects for Malaysia's healthcare sector across Southeast Asia. This commitment is evident in MATRADE's endorsement of the Southeast Asian Healthcare and Pharma Show (SEACare 2024) which scheduled to take place from 17 to 19 April 2024, at the Kuala Lumpur Convention Centre (KLCC).
SEACare 2024 presents a unique opportunity for the local healthcare sector players to enhance their brand recognition and effectively promote their products and services to the Southeast Asia region's market. The event also provides a platform for companies to showcase their commitment to innovation, quality, and sustainability elements in enhancing their reputation and competitive edge in the region.
MATRADE's collaboration with SEACare 2024 includes the International Sourcing Programme (INSP) - strategically crafted to bridge local companies with international buyers. Capitalising its network of 49 overseas offices, MATRADE endeavours to facilitate meetings between around 20 international buyers from the healthcare sector and local suppliers. This initiative aims to enhance networking opportunities, cultivate strong business relationships, and spur collaboration and innovation within the industry.
In 2023, Malaysia's export of medical devices reached RM28.1 billion, with a steady growth from medical instruments and consumables. The New Industrial Master Plan 2030 (NIMP 2030) identifies medical devices and pharmaceuticals as priority sectors and part of the key areas for development. According to MATRADE’s CEO, Datuk Mohd Mustafa Abdul Aziz, Malaysia's healthcare sector is a vital lifeline connecting communities and driving the nation's advancements. He emphasised, “With state-of-the-art medical devices manufacturing facilities and accessible, high-quality pharmaceutical products - Malaysia has emerged as a regional healthcare hub. The country's infrastructure, coupled with specialised medical treatments and affordable fees, makes Malaysia an attractive destination for medical tourism.”
MATRADE champions digitalisation, sustainability practices, and Halal certification to enhance global acceptance of Malaysian products and services. Its dedication to advancing export opportunities for Malaysia's healthcare sector across Southeast Asia is reflected in a range of dynamic activities including impactful trade missions, business matching sessions, and insightful industry seminars. Moreover, MATRADE fosters strategic partnerships with industry leaders, facilitating targeted promotional campaigns, active participation in pivotal industry events, and fostering networking opportunities. Through these measures, the national trade promotion agency aims to amplifying the visibility and strengthening the competitiveness of Malaysia's healthcare industry throughout the region."
Local healthcare players are encouraged to seize the opportunity presented by SEACare 2024 to showcase their offerings. Additionally, industry leaders and stakeholders are invited to stay abreast of the latest trends and developments in medical devices and pharmaceuticals through comprehensive range of conferences and seminars offered as part of the event.
